Related Experiment Video

Updated: Aug 9, 2026

Intracellular Refolding Assay
07:18

Intracellular Refolding Assay

Published on: January 24, 2012

The distinctive role of small heat shock proteins in oncogenesis

Krzysztof Laudanski1, Dorota Wyczechowska

  • 1Department of Medicine, Griffin Hospital, 130 Division St., Derby, CT 06418, USA, and Department of Medicinal Chemistry, Medical University of Łodź, Poland. klaudanski@sbcglobal.net

Archivum Immunologiae Et Therapiae Experimentalis
|May 2, 2006
PubMed

Insights

Small heat shock proteins (HSPs), particularly HSP-27 and alphaA/B-crystallins, are increasingly recognized for their tumor-protective roles. This review explores their potential involvement in early carcinogenesis and tumor growth, including immune suppression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Small heat shock proteins (HSPs) are increasingly recognized for their roles in cancer.
  • HSPs offer tumor protection through mechanisms like oxidative stress resistance, protein stabilization, and anti-apoptosis.
  • Their involvement in the initial stages of carcinogenesis remains largely unexplored.

Purpose of the Study:

  • To review the general characteristics and tissue distribution of small HSPs, focusing on HSP-27 and alphaA/B-crystallins.
  • To examine the biological properties of intracellular HSP-27 and alphaA/B-crystallins that may promote tumor genesis and growth.
  • To discuss the immunomodulatory characteristics of extracellular HSP-27 and their potential impact on neoplasm development.

Main Methods:

  • Literature review and synthesis of existing research on small heat shock proteins in cancer.
  • Analysis of tissue distribution, with emphasis on expression in malignant specimens.
  • Examination of biological and immunomodulatory properties of HSP-27 and alphaA/B-crystallins.

Main Results:

  • Small HSPs exhibit diverse tumor-protective mechanisms, including resistance to oxidative stress and apoptosis.
  • Intracellular HSP-27 and alphaA/B-crystallins possess properties that can drive tumor initiation and progression.
  • Extracellular HSP-27 demonstrates immunomodulatory effects with implications for cancer development.

Conclusions:

  • Small HSPs, including HSP-27 and alphaA/B-crystallins, play multifaceted roles in cancer, potentially influencing early carcinogenesis.
  • Understanding the dual roles of HSPs (protective and tumor-promoting) is crucial for developing targeted cancer therapies.
  • Further research into the immunomodulatory functions of extracellular HSPs may reveal novel therapeutic strategies.

More Related Videos

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors07:57

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors

Published on: January 20, 2023

Using Caenorhabditis elegans to Screen for Tissue-Specific Chaperone Interactions06:55

Using Caenorhabditis elegans to Screen for Tissue-Specific Chaperone Interactions

Published on: June 7, 2020

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...